Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2007
12/27/2007CA2652859A1 Pyrazinones as cellular proliferation inhibitors
12/27/2007CA2649648A1 Adenosine a3 receptor agonists
12/26/2007EP1870408A1 Novel process for producing ramosetron or its salt
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1870099A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
12/26/2007EP1869020A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
12/26/2007EP1869019A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
12/26/2007EP1869018A1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869016A1 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
12/26/2007EP1869013A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
12/26/2007EP1869011A2 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
12/26/2007EP1869006A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
12/26/2007EP1869001A1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine
12/26/2007EP1868994A1 Sulfonylpyrroles as histone deacetylase inhibitors
12/26/2007EP1751138B1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007CN101094850A Olmesartan medoxomil with reduced levels of impurities
12/26/2007CN101094849A Process for preparing olmesartan medoxomil at ph higher than 2.5
12/26/2007CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
12/26/2007CN101094841A Indinavir derivatives useful in immunoassay
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101092413A Hydrate of medicinal salt of Fasudil
12/26/2007CN101092384A A category of compound of alpha ¿C amido - N ¿C substituent amide, its composition, and application
12/26/2007CN100357297C Pyrimidines, methods for the production thereof, and use thereof
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/26/2007CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357271C Hole transport materials with 9-phenyl carbazole as core and process for making same
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100356979C Integrin expression inhibitors
12/25/2007US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007US7312340 Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007US7312235 Anticoagulants
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312215 Anticancer agents
12/25/2007US7312180 Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146914A1 Ghrelin modulating compounds
12/21/2007WO2007146890A2 Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007144174A1 Ethenyl carboxamide derivatives useful as microbiocides
12/21/2007WO2007144128A1 Pyrrolidine compounds as renin inhibitors
12/21/2007WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007WO2007143824A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143823A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007126964A3 Kinase inhibitors
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2007105058A3 Pyrazole compounds
12/21/2007WO2007093529A3 Heteroaroyl-substituted alanines
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007059359A3 Substituted pyrazalones
12/21/2007WO2006036395A3 Inhibitors of akt activity
12/21/2007WO2005051366A3 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2654979A1 Pyrrolidine compounds as renin inhibitors
12/21/2007CA2654792A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654098A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654097A1 Ethenyl carboxamide derivatives useful as microbiocides
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/20/2007US20070293674 Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods
12/20/2007US20070293668 Phenylindoles for the treatment of HIV
12/20/2007US20070293667 Such as (7-chloro-2-styryl-quinazolin-4-yl)-(3-imidazol-1-yl-propyl)-amine; glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors
12/20/2007US20070293507 Pyrazole Kinase Modulators And Methods Of Use
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293494 2-Anilino-4-(Heterocyclic) Amino-Pyrimidines
12/20/2007US20070293490 Quinazoline Derivatives
12/20/2007US20070293455 Silylated Carboxamides
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/20/2007US20070292485 Polyol ester compounds
12/20/2007US20070290610 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
12/20/2007DE102006032168A1 Anthranilsäurediamid-Derivate mit heteroaromatischen Substituenten Anthranilsäurediamid derivatives with heteroaromatic substituents
12/20/2007DE102006027229A1 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxylic acid amides and their use for the preparation of medicaments
12/19/2007EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
12/19/2007EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
12/19/2007EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/19/2007EP1866288A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors
12/19/2007EP1865958A2 Pharmacokinetically improved compounds
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors